CRP and chronic kidney disease: Pentraxin-3 levels were significantly higher in patients with CKD compared to the controls after adjusting for multiple confounding factors including C-reactive protein in our study, even though pentraxin-3 did not increase substantially with increased severity of CKD and the odds of CKD associated with pentraxin-3 did not achieve statistical significance in multivariable logistic analysis.